Rockwell Medical (RMTI) Cash from Investing Activities (QoQ) (2010 - 2026)
Rockwell Medical (RMTI) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -299.18% |
| Mar 31, 2026 | 97.05% |
| Dec 31, 2025 | 4.13% |
| Sep 30, 2025 | -4,083.50% |
| Jun 30, 2025 | -10,200.00% |
| Mar 31, 2025 | 99.70% |
| Dec 31, 2024 | 94.57% |
| Sep 30, 2024 | -455.97% |
| Jun 30, 2024 | 1,335.25% |
| Mar 31, 2024 | -106.92% |
| Dec 31, 2023 | 119.51% |
| Sep 30, 2023 | -15,979.69% |
| Jun 30, 2023 | -101.21% |
| Mar 31, 2023 | 64.76% |
| Dec 31, 2022 | 121.90% |
| Sep 30, 2022 | -28,715.69% |
| Jun 30, 2022 | -100.56% |
| Mar 31, 2022 | 1,591.30% |
| Dec 31, 2021 | 139.59% |
| Sep 30, 2021 | -182.82% |